Traumatic brain injuries have toxic effects that last weeks. Antioxidant addresses that damage in mice
Traumatic brain injury is a leading cause of death and disability in the world. Blunt force trauma to the brain, often from a ...
Traumatic brain injuries have toxic effects that last weeks after initial impact − an antioxidant material reduces this damage in mice
Addressing the harmful chemical processes that accompany blunt force trauma to the brain can reduce the risk of long-term ...
Scientists discover 'genetic weak spot' in endangered Italian bear population
The Apennine brown bear, also known as the Marsican brown bear (Ursus arctos marsicanus), is a unique and critically ...
AZoNano4h
New Cancer Treatment Breakthrough: Photoimmunotherapy Shows Promise in Targeting Tumors
Photoimmunotherapy with the M@P nanoplatform offers a novel approach, triggering cancer cell death and boosting immune ...
Science Daily2d
Function of red stigmas in wind-pollinated flowers
Scientists discovered that the red stigmas in wind-pollinated trees accumulate anthocyanin, the same compounds that are revealed in autumn leaves after green chlorophyll production slows down and ...
Scientists Discover a New Way To Detect Inflammation – And It Could Change Medicine
Chemistry researchers at Case Western Reserve University have identified specific markers that could pave the way for new ...
Investornewsbreaks Telomir Pharmaceuticals (NASDAQ: TELO) Reports Promising Preclinical Results For Age-Related Macular Degeneration
Telomir Pharmaceuticals (NASDAQ: TELO) announced positive preclinical results demonstrating its lead compound, Telomir-1, significantly reduced react ...
Physics World1d
Low-temperature plasma halves cancer recurrence in mice
Treatment with a cold atmospheric plasma reduced the recurrence rate of melanoma tumours after surgery by roughly 50% ...
TELO Again Announces Breakthrough Results
TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...
Telomir Pharmaceuticals announces results from preclinical studies of Telomir-1
Telomir Pharmaceuticals (TELO) announced results from its recent preclinical studies conducted in human retinal cell lines. These studies ...
The Secret to Healthy Aging? Scientists Uncover the Power of Selenoproteins
A research team from Osaka University investigates the impact of antioxidant enzymes on specific cell types and their role in ...